| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,036,071 ) |
| | 2025 | 2025 | HALO BIOSCIENCES INC | 125 UNIVERSITY ST. | PALO ALTO | CA | 94301-1680 | SANTA CLARA | USA | R44HL169052 | Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH) | 000 | 2 | NIH | 3/27/2025 | $1,036,071 |
|
| Issue Date FY: 2024 ( Subtotal = $1,957,305 ) |
| | 2024 | 2024 | HALO BIOSCIENCES INC | 125 UNIVERSITY ST. | PALO ALTO | CA | 94301-1680 | SANTA CLARA | USA | R44HL169052 | Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH) | 000 | 1 | NIH | 5/14/2024 | $1,957,305 |
|
|
